Biosimilars

© GettyImages/Dilok Klaisataporn

Pfizer sells biosimilars plant in China to Wuxi

By Jane Byrne

Pfizer is selling a biologics manufacturing unit in the eastern city of Hangzhou to WuXi Biologics, despite the US pharma giant having ploughed US$350m into the site in 2016 to develop biosimilars.

© GettyImages/ChooChin

UK market sees additional Herceptin biosimilar

By Jane Byrne

Accord Healthcare has announced the launch of a Herceptin biosimilar in the UK. Zercepac is the first monoclonal antibody (mAb) and fourth biosimilar launched by the company in Europe.

Follow us

Products

View more

Webinars